Scientists at an Australian biotechnology company explain the process of creating Covid-19 jabs that are likely to end up in New Zealand.
CSL has begun producing the Oxford/AstraZeneca vaccine, after receiving a contract to manufacture 50 million doses. Covid-19 Minister Chris Hipkins has said it is likely New Zealand’s doses of AstraZeneca would come from Australian manufacturers.
Representatives from CSL and Seqirus’ advanced manufacturing facilities in Victoria explain the process of manufacturing the AstraZeneca vaccine – starting from the first ‘vial thaw’ through to ‘harvest’ of the product in bulk, to formulation and ‘fill and finish’ into dose vials.
Declaration: CSL is a supporter of the Australian Science Media Centre and contributes ~1% of the Centre’s budget. See all our supporters and read about our independence.
Click here to watch the AusSMC briefing through the Zoom cloud service.
